TEKZOR 50 MG COM REV CT BL AL PLAS OPC X 60

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1058307330017
  • GGREM 526137201112413
  • Código de barras 7896004728995

O que a fonte publica

Detentor do registro
GERMED FARMACEUTICA LTDA
Princípios ativos
RILUZOL
Embalagem
50 MG COM REV CT BL AL PLAS OPC X 60
Tipo de produto
Similar
Classe terapêutica
N7X - TODOS OS OUTROS PRODUTOS PARA O SISTEMA NERVOSO CENTRAL

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:526137201112413
{
  "name": "TEKZOR 50 MG COM REV CT BL AL PLAS OPC X 60",
  "holder": "GERMED FARMACEUTICA LTDA",
  "stripe": null,
  "barcodes": [
    "7896004728995"
  ],
  "confaz87": true,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "526137201112413",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "45.992.062/0001-65",
  "priceRegime": "Regulado",
  "productName": "TEKZOR",
  "productType": "Similar",
  "hospitalOnly": false,
  "presentation": "50 MG COM REV CT BL AL PLAS OPC X 60",
  "sourceStatus": null,
  "supplyRegime": null,
  "factoryPrices": {
    "icms-0": "2416.13",
    "icms-12": "2745.60",
    "icms-17": "2911.00",
    "icms-18": "2946.50",
    "icms-19": "2982.88",
    "icms-20": "3020.16",
    "icms-21": "3058.39",
    "icms-22": "3097.60",
    "icms-23": "3137.83",
    "icms-17.5": "2928.64",
    "icms-19.5": "3001.40",
    "icms-20.5": "3039.16",
    "icms-22.5": "3117.59",
    "icms-12-alc": "2712.65",
    "icms-17-alc": "2876.07",
    "icms-18-alc": "2911.14",
    "icms-19-alc": "2947.08",
    "icms-20-alc": "2983.92",
    "icms-21-alc": "3021.69",
    "icms-22-alc": "3060.43",
    "icms-23-alc": "3100.18",
    "withoutTaxes": "2387.14",
    "icms-17.5-alc": "2893.50",
    "icms-19.5-alc": "2965.39",
    "icms-20.5-alc": "3002.69",
    "icms-22.5-alc": "3080.18"
  },
  "pisCofinsList": "Positiva",
  "substanceText": "RILUZOL",
  "targetSpecies": [],
  "consumerPrices": {
    "icms-0": "3330.38",
    "icms-12": "3784.52",
    "icms-17": "4012.51",
    "icms-18": "4061.44",
    "icms-19": "4111.59",
    "icms-20": "4162.98",
    "icms-21": "4215.67",
    "icms-22": "4269.72",
    "icms-23": "4325.17",
    "icms-17.5": "4036.83",
    "icms-19.5": "4137.12",
    "icms-20.5": "4189.17",
    "icms-22.5": "4297.27",
    "icms-12-alc": "3750.08",
    "icms-17-alc": "3976.00",
    "icms-18-alc": "4024.48",
    "icms-19-alc": "4074.17",
    "icms-20-alc": "4125.09",
    "icms-21-alc": "4177.31",
    "icms-22-alc": "4230.86",
    "icms-23-alc": "4285.82",
    "withoutTaxes": "3300.08",
    "icms-17.5-alc": "4000.09",
    "icms-19.5-alc": "4099.48",
    "icms-20.5-alc": "4151.04",
    "icms-22.5-alc": "4258.17"
  },
  "invalidBarcodes": [],
  "activeSubstances": [
    "RILUZOL"
  ],
  "therapeuticClass": "N7X - TODOS OS OUTROS PRODUTOS PARA O SISTEMA NERVOSO CENTRAL",
  "commercialisation": {
    "year": 2025,
    "marketed": false
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1058307330017",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "prescriptionRequired": null,
  "therapeuticClassCode": "N7X",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:526137201112413"